Financials data is unavailable for this security.
Cash flow in USDView more
In 2024, Centessa Pharmaceuticals PLC increased its cash reserves by 199.32%, or 255.19m. Cash Flow from Financing totalled 364.75m or -- of revenues. In addition the company used 142.06m for operations while cash from investing totalled 31.27m.
| Cash flow per share | -1.81 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 2.24 |
|---|---|
| Tangible book value per share | 2.24 |
More ▼
Balance sheet in USDView more
| Current ratio | 10.57 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.3641 |
|---|---|
| Total debt/total capital | 0.2669 |
More ▼
